z-logo
open-access-imgOpen Access
Survival of veterans treated with enzalutamide and abiraterone for metastatic castrate resistant prostate cancer based on comorbid diseases
Author(s) -
Martin W. Schoen,
Kenneth R. Carson,
Seth A. Eisen,
Charles L. Bennett,
Suhong Luo,
Melissa A. Reimers,
E. Knoche,
Alison L. Whitmer,
Yan Yan,
Bettina F. Drake,
Kristen M. Sanfilippo
Publication year - 2022
Publication title -
prostate cancer and prostatic diseases
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2
H-Index - 64
eISSN - 1476-5608
pISSN - 1365-7852
DOI - 10.1038/s41391-022-00588-5
Subject(s) - enzalutamide , medicine , prostate cancer , veterans affairs , oncology , comorbidity , abiraterone , population , cancer , androgen receptor , environmental health

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here